Evotec (EVO) Institutional Ownership $4.11 +0.07 (+1.73%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Evotec (NASDAQ:EVO)CurrentInstitutional OwnershipPercentage5.81%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$129.38MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$348.40K Get EVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Evotec stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVO Institutional Buying and Selling by Quarter Evotec Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Wellington Management Group LLP2,634,434$9.62M0.0%+29.7%0.743% 10/24/2024Clear Harbor Asset Management LLC28,600$104K0.0%N/A0.008% 10/23/2024Mediolanum International Funds Ltd140,383$512K0.0%N/A0.040% 8/20/2024Novo Holdings A S14,829,842$71.18M3.6%N/A4.185% 8/13/2024DCF Advisers LLC114,953$552K0.3%+140.5%0.032% 8/12/2024Vanguard Personalized Indexing Management LLC19,233$87K0.0%N/A0.005% 5/24/2024Cetera Advisors LLC24,043$188K0.0%N/A0.007% 3/5/2024Mubadala Investment Co PJSC4,597,701$53.93M0.2%N/A1.297% 2/13/2024Optiver Holding B.V.80,810$945K0.0%+643.1%0.023% 2/8/2024Quadrant Capital Group LLC2,130$25K0.0%N/A0.001% 1/31/2024Federated Hermes Inc.576,933$6.74M0.0%-0.3%0.163% 1/30/2024Zurcher Kantonalbank Zurich Cantonalbank174,266$2.04M0.0%-13.9%0.049% 11/13/2023Optiver Holding B.V.10,874$107K0.0%-68.0%0.003% 11/13/2023Federated Hermes Inc.578,533$5.71M0.0%-22.9%0.163% 10/25/2023Zurcher Kantonalbank Zurich Cantonalbank202,368$2.00M0.0%-6.2%0.057% (Data available from 1/1/2016 forward) EVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVO shares? During the previous two years, 12 institutional investors and hedge funds held shares of Evotec. The most heavily invested institutionals were Novo Holdings A S ($71.18M), Mubadala Investment Co PJSC ($53.93M), Wellington Management Group LLP ($9.62M), Federated Hermes Inc. ($6.74M), Zurcher Kantonalbank Zurich Cantonalbank ($2.04M), Optiver Holding B.V. ($945K), and DCF Advisers LLC ($552K).Learn more on EVO's institutional investors. What percentage of Evotec stock is owned by institutional investors? 5.81% of Evotec stock is owned by institutional investors. Learn more on EVO's institutional investor holdings. Which institutional investors have been buying Evotec stock? Of the 10 institutional investors that purchased Evotec stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Novo Holdings A S ($14.83M), Mubadala Investment Co PJSC ($4.60M), Wellington Management Group LLP ($602.86K), Mediolanum International Funds Ltd ($140.38K), Optiver Holding B.V. ($69.94K), DCF Advisers LLC ($67.16K), and Clear Harbor Asset Management LLC ($28.60K). How much institutional buying is happening at Evotec? Institutional investors have bought a total of 20,381,882 shares in the last 24 months. This purchase volume represents approximately $129.38M in transactions. Which Evotec major shareholders have been selling company stock? The following institutional investors have sold Evotec stock in the last 24 months: Federated Hermes Inc. ($173.07K), Zurcher Kantonalbank Zurich Cantonalbank ($41.40K), and Optiver Holding B.V. ($23.08K). How much institutional selling is happening at Evotec? Institutional investors have sold a total of 237,551 shares in the last 24 months. This volume of shares sold represents approximately $2.40M in transactions. Related Companies Legend Biotech Major Shareholders Elanco Animal Health Major Shareholders Cytokinetics Major Shareholders Nuvalent Major Shareholders Grifols Major Shareholders TG Therapeutics Major Shareholders Viking Therapeutics Major Shareholders Axsome Therapeutics Major Shareholders Krystal Biotech Major Shareholders Organon & Co. Major Shareholders This page (NASDAQ:EVO) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVO Stock Alerts